Evidence map›Paper›PMID 39635442›Full record

ArticleNanophotonics (Berlin, Germany)2024

Strongly coupled plasmon-exciton polaritons for photobleaching suppression.

Justina Anulytė, Vytautas Žičkus, Ernesta Bužavaitė-Vertelienė, Daniele Faccio, Zigmas Balevičius

Abstract read
In one paragraph

Article in Nanophotonics (Berlin, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Justina AnulytėDepartment of Laser Technologies, Center for Physical Sciences and Technology, Vilnius 10257, Lithuania.
Vytautas ŽičkusDepartment of Laser Technologies, Center for Physical Sciences and Technology, Vilnius 10257, Lithuania.ORCID https://orcid.org/0000-0003-4042-2091
Ernesta Bužavaitė-VertelienėDepartment of Laser Technologies, Center for Physical Sciences and Technology, Vilnius 10257, Lithuania.ORCID https://orcid.org/0000-0003-2436-6528
Daniele FaccioSchool of Physics and Astronomy, University of Glasgow, Glasgow G12 8QQ, UK.
Zigmas BalevičiusDepartment of Laser Technologies, Center for Physical Sciences and Technology, Vilnius 10257, Lithuania.ORCID https://orcid.org/0000-0002-8757-4335

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Strong light-matter interactions have received a lot of attention, for example in the pursuit of plasmonic-excitonic structures as coherent light sources with low-power threshold. In this study, we investigate the influence of room temperature strong coupling between surface plasmon polaritons (SPP) and excitons on fluorescence lifetimes and photobleaching effects. Our plasmonic-photonic structure, comprising of thin silver (Ag) and gold (Au) layers with a Rhodamine 6G (R6G) dye layer, shows a clear shift in the plasmon resonance and R6G absorption lines with varying incident angles, indicative of strong coupling, with a measured Rabi splitting of approximately 90 meV. Fluorescence lifetime imaging microscopy (FLIM) was then employed to assess photobleaching, revealing a significant reduction in photobleaching effect for in strongly coupled plasmonic-excitonic structures compared to single Rhodamine R6G layers. Our findings indicate the pivotal role of strong light-matter interactions in reducing photobleaching effects and stabilizing fluorescence intensities, offering promising avenues for developing quantum multiparticle nanophotonic devices with enhanced stability and performance.

Indexed as

photobleachingplasmon exciton couplingpolaritonsstrong coupling

Identifiers

PMID39635442
PMCPMC11501053

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.